Spanish Distribution Firm Turns to ReadSoft for Invoices Capture
May 02, 2002 04:09 ET
|
ReadSoft
STOCKHOLM, Sweden, May 2, 2002 (PRIMEZONE) -- ReadSoft has closed a deal with the largest Pharmaceutical Distribution Group in Spain, Unycop, who will use ReadSoft's software INVOICES to process...
Medivir: Interim Report, 1 January - 31 March 2002 (with link)
April 26, 2002 05:33 ET
|
Medivir
HUDDINGE, Sweden, April 26, 2002 (PRIMEZONE) -- Medivir:
- MIV-606 against shingles: US market rights outlicensed to Reliant
Pharmaceuticals, raising a SEK 50 m up-front payment. Medivir...
Pharmexa A/S: Inoxell Receives Acceptance of its Scaffold Technology Patent from the European Patent Office
April 24, 2002 11:16 ET
|
Pharmexa A/S
HORSHOLM, Denmark, April 24, 2002 (PRIMEZONE) -- Pharmexa's 83.3% owned subsidiary Inoxell A/S today announced that the European Patent Office has issued an acceptance of Inoxell's patent on its...
CeNeS Announces Preliminary Results for the Year- Ended December 31, 2001 (with link)
March 27, 2002 03:16 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., March 27, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced its results for the year ended Dec. 31, 2001 and an update on its restructuring plan.
Key events...
Solvay Group: Final 2001 Results; Confirmation of Net Current Earnings of EUR 403 million; Net Dividend Maintained at EUR 1.70 per Share
March 22, 2002 03:03 ET
|
CompanynewsGroup
BRUSSELS, Belgium, March 22, 2002 (PRIMEZONE) -- Results of the Solvay Group (Euronext Brussels:SOLB) (Xetra:SOL) and the parent company, Solvay S.A.
As announced on February 18, 2002, the Solvay...
BioPhausia: Year end report 2001 (with link)
February 27, 2002 13:15 ET
|
BioPhausia
UPPSALA, Sweden, February 27, 2002 (PRIMEZONE) -- BioPhausia reports year-end results and significant events.
-- Sales amounted to SEK 2.071.000 (SEK 975.000)
-- Rights for RescueFlow(r)...
Tripep AB publ: Year-End 2001 (with links)
January 25, 2002 04:15 ET
|
Tripep
HUDDINGE, Sweden, Jan. 25, 2002 (PRIMEZONE) -- Tripep AB (publ):
-- New plan adopted, entailing three areas of operation for Tripep:
-- the HIV-inhibiting pharmaceutical GPG(r),
-- a...